Suspected cardiac toxicity to intravenous immunoglobulin used for treatment of scleromyxedema.
Indian J Dermatol Venereol Leprol
;
2008 May-Jun; 74(3): 248-50
Artigo
em Inglês
| IMSEAR
| ID: sea-52857
ABSTRACT
Scleromyxedema is a rare, generalized form of lichen myxedematosus, which may be associated with systemic involvement and can be fatal. The therapeutic options available provide partial or inconsistent response and are associated with significant adverse effects. We report a case of scleromyxedema with cardiac involvement, treated with low-dose intravenous immunoglobulin, with almost complete clearing of the skin lesions. The patient died after three cycles of treatment, possibly due to myocardial infarction.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Humanos
/
Masculino
/
Fatores de Risco
/
Imunoglobulinas Intravenosas
/
Morte Súbita Cardíaca
/
Evolução Fatal
/
Adulto
/
Eletrocardiografia
/
Escleromixedema
/
Cardiopatias
Tipo de estudo:
Estudo de etiologia
/
Fatores de risco
Idioma:
Inglês
Revista:
Indian J Dermatol Venereol Leprol
Ano de publicação:
2008
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS